Timothy P. Walbert Joins Sucampo's Board of Directors
13 oct. 2015 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 13, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that Timothy P. Walbert has joined Sucampo's...
Sucampo Launches Tender Offer to Acquire R-Tech Ueno
26 août 2015 06h17 HE
|
Sucampo Pharmaceuticals Inc
Acquisition Expected to be Immediately Accretive
Advances Sucampo Strategy to Strengthen Financial Performance and Diversify Pipeline
Acquisition Expected to Close in Q4 2015
Company to Host...
Sucampo Reports Second Quarter 2015 Financial Results and Corporate Update
05 août 2015 06h30 HE
|
Sucampo Pharmaceuticals Inc
Year-over-Year Earnings Growth of 495% and EPS Growth of 425%
Year-over-Year Revenue Growth of 45%
Company Increases 2015 Earnings Guidance
Company to Host Conference Call Today at 8:30 a.m....
Sucampo Announces Second Quarter 2015 Earnings Call
22 juil. 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., July 22, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its second quarter 2015...
Sucampo Announces Webcast of Its Presentation at Cantor Fitzgerald's Inaugural Healthcare Conference
01 juil. 2015 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., July 1, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
China Food and Drug Administration Accepts IND for Pivotal Study of AMITIZA(R) (lubiprostone)
15 juin 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., June 15, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global pharmaceutical company, today announced that the China Food and Drug Administration...
Sucampo Announces Webcast of Its Presentation at the Jefferies 2015 Healthcare Conference
27 mai 2015 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 27, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Announces Clinical Data on Lubiprostone to be Presented at Digestive Disease Week
15 mai 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 15, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that clinical data for lubiprostone will be...
Sucampo Announces Webcast of Its Presentation at the 2015 UBS Global Healthcare Conference
13 mai 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 13, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo and Harbin Gloria Pharmaceuticals Enter Into Licensing Agreement for AMITIZA(R) (lubiprostone) in China
11 mai 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 11, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global pharmaceutical company, today announced that it entered into an exclusive license,...